SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending due to conflicting but significant news, with the successful unfolding of its large BlueBird 6 satellite marking a major technological de-risking, validating its direct-to-device capability. This positive development and the stock's inclusion in the MSCI World Index are being discussed alongside a proposed $1 billion convertible senior notes offering, prompting community debate over long-term growth versus immediate capital needs and potential dilution.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

Applovin is actively discussed following a double beat on recent earnings with impressive revenue growth and an expanding Axon AI engine, yet the community is perplexed by the initial negative price action amidst broader software sector jitters, despite a prior short-seller retraction that de-risked the stock.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Oral VK2735 advancing to Phase 3 is driving conversation for Viking Therapeutics, with the community discussing this acceleration as a major validation and fueling speculation around potential partnerships or a buyout amidst positive broader market dynamics for legitimate GLP-1 players.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending amidst mixed investor reactions to its latest shareholder letter and Q4 earnings, which underscore ongoing cash burn and its pre-revenue status, fueling community frustration. Simultaneously, optimistic discussions revolve around the Eagle Line pilot production as a key step towards scalable solid-state battery commercialization through licensing and future OEM partnerships.

HubSpot, Inc. engages in cloud-based customer relationship management. Its platform includes marketing, sales, service, operations and content management system, as well as other tools, integrations and native payment solutions. It operates through the following geographical segments: Americas, Europe and Asia Pacific. The company was founded by Brian Patrick Halligan and Dharmesh Shah on April 4, 2005, and is headquartered in Cambridge, MA.

HubSpot Inc

HubSpot is trending after reporting strong earnings, raising its outlook, and announcing a $1 billion share repurchase program, yet the stock experienced a significant drop, fueling investor frustration and a community debate over whether "AI fears" are unfairly impacting SaaS valuations.

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Fastly is surging after reporting a substantial earnings beat and robust forward guidance, prompting community excitement about the company's turnaround and its positioning to benefit from increasing AI demand at the edge. Many are discussing a potential breakout and renewed growth for the stock, though some caution profit-taking after the significant price movement.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Cisco is trending following an earnings beat and raised guidance, fueled by robust demand for AI infrastructure, prompting community discussion around the stock nearing its dot-com era highs and its valuation in the current tech cycle.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending due to its recent FDA approval of NEREUS for motion sickness and strong anticipation for the February PDUFA of Bysanti for bipolar I and schizophrenia. Despite a recent jet lag drug rejection, the community sees immense value in its Tradipitant program for GLP-1 induced nausea, driving significant buyout speculation and a belief the company is deeply undervalued.

McDonald's Corp. engages in the operation and franchising of restaurants. It operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. The firm's products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, McCafe beverages, and other beverages. The company was founded by Raymond Albert Kroc on April 15, 1955, and is headquartered in Oak Brook, IL.

McDonald`s Corp

McDonald's Corp

McDonald's is trending after recent financial results showed an earnings and revenue beat, fueled by the success of its value strategy and digital loyalty programs. Community conversations highlight these initiatives for attracting cost-conscious consumers amidst broader discussions on fast-food pricing and inflation.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Churchill Capital Corp X - Ordinary Shares - Class A

Churchill Capital Corp X 

Churchill Capital Corp X (CCCX) is heavily trending as its anticipated merger with quantum technology firm Infleqtion nears, driven by significant new contracts with NASA and the U.S. Department of Energy. The community is buzzing with comparisons to other quantum stocks, touting Infleqtion as a "criminally undervalued" leader with substantial long-term potential, while closely watching for a post-merger surge.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Biofrontera Inc. (BFRI) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

Biofrontera Inc. (BFRI) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

Is Biofrontera Inc. (BFRI) Stock Outpacing Its Medical Peers This Year?

Here is how Biofrontera Inc. (BFRI) and Brookdale Senior Living (BKD) have performed compared to their sector so far this year.

Biofrontera Earnings Preview

Roivant Sciences Ltd. (ROIV) Reports Q2 Loss, Lags Revenue Estimates

Montes Archimedes Acquisition (ROIV) delivered earnings and revenue surprises of -3.70% and -75.13%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Lifecore Biomedical (LFCR) Reports Q1 Loss, Beats Revenue Estimates

Lifecore Biomedical (LFCR) delivered earnings and revenue surprises of +3.33% and +16.60%, respectively, for the quarter ended August 2025. Do the numbers hold clues to what lies ahead for the stock?

Viridian Therapeutics, Inc. (VRDN) Reports Q3 Loss, Tops Revenue Estimates

Viridian Therapeutics (VRDN) delivered earnings and revenue surprises of +58.54% and +50.85%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

PTC Therapeutics (PTCT) Q3 Earnings and Revenues Top Estimates

PTC Therapeutics (PTCT) delivered earnings and revenue surprises of +116.81% and +20.17%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Lineage Cell (LCTX) Reports Q2 Loss, Beats Revenue Estimates

Lineage Cell (LCTX) delivered earnings and revenue surprises of +50.00% and +75.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Pacific Biosciences of California (PACB) Reports Q2 Loss, Beats Revenue Estimates

Pacific Biosciences (PACB) delivered earnings and revenue surprises of +27.78% and +9.06%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Tarsus Pharmaceuticals, Inc. (TARS) Reports Q2 Loss, Tops Revenue Estimates

Tarsus Pharmaceuticals (TARS) delivered earnings and revenue surprises of -45.45% and +9.94%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Biofrontera, Inc. is a biopharmaceutical company, which engages in the commercialization of pharmaceutical products. It specializes in the treatment of dermatological conditions, caused primarily by exposure to sunlight that results in sun damage to the skin. The company focuses on the treatment of actinic keratosis and markets a topical antibiotic for treatment of impetigo. Its products include Ameluz and Xepi, its two prescription drugs, and BF-RhodoLED, a lamp used with Ameluz, for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company was founded on March 3, 2015 and is headquartered in Woburn, MA.

Biofrontera Inc

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $COIN earnings on Thursday?

BFRI
Biofrontera Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest BFRI News

BFRIBiofrontera Inc